Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devico

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Patterns of conserved gp120 epitope presentation on attached HIV-1 virionsMeron Mengistu, Ai-Hui Tang, James S Foulke, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infectionYongjun Guan, Mohammad M Sajadi, Roberta Kamin-Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free statusA Garzino-Demo, R B Moss, J B Margolick, et al.
Journal of Human Virology|September 28, 2002
Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartmentsDavid M Hone, Anthony L DeVico, Timothy R Fouts, et al.
AIDS Research and Human Retroviruses|April 13, 2023
Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung CancerBen Atkinson, Abdolrahim Abassi, Mohammad M Sajadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNasesFiorenza Cocchi, Anthony L DeVico, Wuyuan Lu, et al.
Journal of Virology|April 8, 2021
Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody ImprovementQingbo Liu, Peng Zhang, Huiyi Miao, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|May 9, 2023
Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature ReviewNaomie Devico Marciano, Ryan S Beyer, Andrew Nguyen, et al.
JAMA|August 9, 1985
Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an associationH W Jaffe, M G Sarngadharan, A L DeVico, et al.
Clinical and Vaccine Immunology : CVI|May 20, 2016
An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus MacaquesJennifer A Schwartz, Ilia Prado, Johnathan Misamore, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Patterns of conserved gp120 epitope presentation on attached HIV-1 virionsMeron Mengistu, Ai-Hui Tang, James S Foulke, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infectionYongjun Guan, Mohammad M Sajadi, Roberta Kamin-Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free statusA Garzino-Demo, R B Moss, J B Margolick, et al.
Journal of Human Virology|September 28, 2002
Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartmentsDavid M Hone, Anthony L DeVico, Timothy R Fouts, et al.
AIDS Research and Human Retroviruses|April 13, 2023
Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung CancerBen Atkinson, Abdolrahim Abassi, Mohammad M Sajadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNasesFiorenza Cocchi, Anthony L DeVico, Wuyuan Lu, et al.
Journal of Virology|April 8, 2021
Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody ImprovementQingbo Liu, Peng Zhang, Huiyi Miao, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|May 9, 2023
Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature ReviewNaomie Devico Marciano, Ryan S Beyer, Andrew Nguyen, et al.
JAMA|August 9, 1985
Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an associationH W Jaffe, M G Sarngadharan, A L DeVico, et al.
Clinical and Vaccine Immunology : CVI|May 20, 2016
An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus MacaquesJennifer A Schwartz, Ilia Prado, Johnathan Misamore, et al.
Pageof 13